Peptide Profile
Leuprolide
A powerful GnRH agonist that helps manage hormone-sensitive conditions by controlling hormone production.
Dose Range
3.75 mg-45 mgmonthly or 3-month injections (depending on formulation)
Frequency
Once daily
Route
Subcutaneous injection (daily)
Cycle Length
Ongoing/indefinite
Onset
Moderate (1-2 weeks)
Evidence
Strong
Compound Profile
Scientific & Efficacy Data
C59H84N16O12
Molecular Formula
1209.4 g/mol
Molecular Weight
Approximately 2-6 hours (varies by route of administration)
Half-Life
~95% (subcutaneous injection)
Bioavailability
74381-53-6
CAS #
657181
PubChem ID ↗
Developed By · 1985
TAP Pharmaceuticals Research Team
TAP Pharmaceuticals (Abbott Laboratories & Takeda joint venture)
Primary Benefits
Effectively reduces testosterone in men with prostate cancer
Relieves severe endometriosis pain and symptoms
Reversible hormone suppression with minimal long-term effects
Amino Acid Sequence
pyroGlu-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEtDosing
How much
do I take?
Timing
Best time to take
Administer Leuprolide at the same time each day (or on the same day each week for weekly injections). Many users prefer morning or evening administration. Pick a time you'll remember consistently.
With food?
Leuprolide injections can be given regardless of meal timing. However, if GI effects occur, administering on an empty stomach or with a light meal may help reduce discomfort.
If stacking
Leuprolide should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.
Adjusting Your Dose
Increase if
- +You've tolerated the current dose for the recommended period without significant side effects
- +Therapeutic goals haven't been met at the current dose level
- +Your healthcare provider recommends dose escalation based on your response
- +Lab work or clinical assessments support a higher dose
Decrease if
- -Side effects are bothersome or impacting daily life despite management strategies
- -You experience any signs of an adverse reaction
- -Lab results indicate the need for dose reduction
- -Your healthcare provider recommends a lower dose based on your response
Signs of right dose
- ✓Therapeutic goals being met with minimal side effects
- ✓Stable and consistent response to treatment
- ✓Lab values or clinical markers trending in the right direction
- ✓Good tolerance with manageable or absent side effects
Dosing Calculator
Calculate Your Exact Dose
Step 1: Peptide Weight
Find the weight printed on your peptide vial label
Look here!
The peptide weight is printed on the label
Look here!
The weight is on the label
Suitability
Is this
right for me?
Best For
Managing advanced or metastatic prostate cancer
Leuprolide is particularly well-suited for individuals focused on managing advanced or metastatic prostate cancer. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Controlling severe endometriosis pain
Leuprolide is particularly well-suited for individuals focused on controlling severe endometriosis pain. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Treating symptomatic uterine fibroids
Leuprolide is particularly well-suited for individuals focused on treating symptomatic uterine fibroids. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Delaying early puberty in children
Leuprolide is particularly well-suited for individuals focused on delaying early puberty in children. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Consider Alternatives If
Who Should Avoid
Do not use if
- ×Pregnancy or breastfeeding (teratogenic)
- ×Undiagnosed vaginal bleeding
- ×Active bone metastases with spinal cord compression (increased fracture risk)
- ×Allergy to GnRH agonists or components
- ×Severe cardiovascular disease with QT prolongation risk
Use with caution if
- !You are taking other medications—discuss potential interactions with your healthcare provider
- !You have a history of liver or kidney disease
- !You are elderly or have multiple medical conditions
- !You are planning surgery in the near future—inform your surgeon about Leuprolide use
- !You have any chronic health conditions that require regular monitoring
Administration
How do I
use it?
Reconstitution
What you need
- •Leuprolide vial (lyophilized powder or solution)
- •Bacteriostatic water or sterile sodium chloride for reconstitution
- •Alcohol swabs for cleaning vial tops and injection sites
- •Appropriately sized syringes with fine-gauge needles (27-30 gauge)
- •Sharps disposal container
Injection
Route
Subcutaneous injection (into the fatty tissue just under the skin)—allows for consistent absorption and can be self-administered at home after proper training
Best sites
- •Abdomen (stomach area)—at least 2 inches from the belly button, most popular choice for self-injection
- •Front of thighs—middle to upper portion of the outer leg
- •Back of upper arm—outer area (may need assistance from another person)
Technique
- 1.Wash your hands thoroughly with soap and water before handling supplies
- 2.Clean the injection site with an alcohol swab and let it air dry completely
- 3.Pinch a fold of skin at the chosen injection site
- 4.Insert the needle at a 45-90 degree angle (depending on needle length and body composition)
- 5.Inject the medication slowly and steadily over 5-10 seconds
- 6.Release the skin fold and remove the needle, applying gentle pressure with a clean swab
- 7.Rotate injection sites to prevent tissue irritation or lipodystrophy
- 8.Dispose of the needle safely in a sharps container—never recap or reuse needles
Storage
Signs of degradation
Sample Daily Schedule
Safety
Is it
safe?
Safety Profile
Leuprolide (Lupron) is an FDA-approved GnRH agonist with 35+ years of clinical safety data involving millions of patients in oncology and endocrinology. The critical safety issue is the initial 5-7 day flare effect—temporary surge in FSH/LH causing symptom worsening before hormone suppression begins—particularly dangerous for prostate cancer patients (flare can cause urinary obstruction or spinal cord compression). Bone density loss is a dose-dependent long-term risk in both men and women requiring monitoring. Injection site reactions, hot flushes, and initial hypogonadal symptoms are expected and typically transient.
Leuprolide safety is well-established through FDA registration trials, extensive post-marketing surveillance, and hundreds of published clinical studies spanning endometriosis, prostate cancer, precocious puberty, and breast cancer indications. Long-term safety data from 10+ years of continuous therapy shows predictable hypogonadal effects with manageable metabolic consequences when monitored appropriately. Black box warnings exist for flare risk in certain prostate cancer scenarios and bone loss risk in extended use.
Common Side Effects
Experienced by some users
Hot flashes (very common in men)
Hot flashes (very common in men)
Management: Consult your healthcare provider for guidance.
Decreased libido and erectile dysfunction
Decreased libido and erectile dysfunction
Management: Consult your healthcare provider for guidance.
Injection site pain or swelling
Injection site pain or swelling
Management: Consult your healthcare provider for guidance.
Nausea
Nausea
Management: Consult your healthcare provider for guidance.
Fatigue
Fatigue
Management: Consult your healthcare provider for guidance.
Mood changes or depression
Mood changes or depression
Management: Consult your healthcare provider for guidance.
Joint or muscle pain
Joint or muscle pain
Management: Consult your healthcare provider for guidance.
Headaches
Headaches
Management: Consult your healthcare provider for guidance.
Dizziness
Dizziness
Management: Consult your healthcare provider for guidance.
Thinning hair
Thinning hair
Management: Consult your healthcare provider for guidance.
Decreased bone density (osteoporosis with long-term use)
Decreased bone density (osteoporosis with long-term use)
Management: Consult your healthcare provider for guidance.
QT prolongation (rare but serious cardiac effect)
QT prolongation (rare but serious cardiac effect)
Management: Consult your healthcare provider for guidance.
Tumor flare (temporary worsening of cancer symptoms in first weeks)
Tumor flare (temporary worsening of cancer symptoms in first weeks)
Management: Consult your healthcare provider for guidance.
Severe allergic reactions
Severe allergic reactions
Management: Consult your healthcare provider for guidance.
Spinal cord compression risk in men with metastatic disease
Spinal cord compression risk in men with metastatic disease
Management: Consult your healthcare provider for guidance.
Stop and Seek Help If
- ×Severe or worsening side effects that don't improve with dose adjustment or supportive care
- ×Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
- ×Your healthcare provider recommends discontinuation based on your clinical response
- ×Development of any new medical condition that may be contraindicated with Leuprolide
- ×Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
- ×Abnormal lab results or clinical markers that suggest adverse effects
Leuprolide should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
Interactions
With other peptides
- ✓May be used together under medical guidance.
- ✓May be used together under medical guidance.
- ✓May be used together under medical guidance.
With medications
- !Other GnRH agonists (would cause overdosing) - Use with caution—discuss with your healthcare provider.
- !Certain medications that prolong QT interval - Use with caution—discuss with your healthcare provider.
- !Avoid if taking medications that significantly interact with testosterone suppression - Use with caution—discuss with your healthcare provider.
With supplements
- ✓Multivitamins - Generally safe to take alongside Leuprolide. Space doses apart if taking oral formulations to ensure optimal absorption.
- ✓Electrolyte supplements - Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.
Effectiveness
Does it
work?
Evidence Level
Strong human trials
What to Expect
initial_response
What you might notice
- •May experience tumor flare (temporary worsening) if used for cancer;
- •hot flashes and decreased libido begin
What's normal
- •Full integration of Leuprolide into physiological systems is established
- •Long-term Leuprolide response remains personalized to your physiology
- •Leuprolide tolerance is well-maintained with consistent dosing
What's next
- →Maintain your established Leuprolide protocol for sustained benefits
- →Continue periodic monitoring to confirm Leuprolide efficacy
- →Review comprehensive Leuprolide response with your provider
peak_effect
What you might notice
- •Full testosterone suppression achieved;
- •endometriosis pain relief becomes noticeable;
- •tumor flare typically resolves
What's normal
- •Leuprolide has achieved stable, long-term homeostatic integration
- •Sustained efficacy of Leuprolide remains consistent
- •Chronic Leuprolide effects remain stable and predictable
What's next
- →Maintain your established Leuprolide protocol for sustained benefits
- →Continue periodic monitoring to confirm Leuprolide efficacy
- →Review comprehensive Leuprolide response with your provider
long_term
What you might notice
- •Sustained hormone suppression;
- •continued symptom relief;
- •bone density monitoring becomes important;
- •most side effects stabilize
What's normal
- •Full therapeutic effects of Leuprolide are well-characterized at this point
- •Maintenance of Leuprolide's therapeutic effects is typical
- •Tolerance patterns with Leuprolide are generally stable over months
What's next
- →Comprehensive assessment of Leuprolide efficacy should be conducted
- →Discuss long-term continuation, cycling, or protocol modifications
- →Continue regular monitoring of relevant biomarkers or symptoms
Signs It's Working
Treatment Response
- ✓Improvement in the primary symptoms or condition being treated
- ✓Positive changes in relevant lab values or clinical markers
- ✓Consistent, stable response to Leuprolide over time
- ✓Reduction in symptom frequency or severity
General Well-being
- ✓Improved energy levels and daily functioning
- ✓Better quality of life related to the treated condition
- ✓Manageable or absent side effects indicating good tolerance
- ✓Positive feedback from healthcare provider during check-ups
Not Seeing Results?
Common reasons
- •Not at therapeutic dose yet—initial doses are for building tolerance, not maximum effect
- •Insufficient time at target dose—most compounds need several weeks to show full benefits
- •Inconsistent dosing schedule—regular, consistent use is crucial for optimal results
- •Individual variation in response—genetics, metabolism, and other factors affect outcomes
- •Underlying conditions or medications interfering with absorption or effectiveness
- •Improper storage leading to degraded product—always verify proper storage conditions
Key Research
"Leuprolide"
Swayzer DV, Gerriets V, 2025
Finding: Leuprolide, a GnRH agonist nonapeptide, is essential for managing prostate cancer, endometriosis, uterine fibroids, and precocious puberty by suppressing sex hormones through pituitary desensitization. Over four decades of clinical use has proven its safety and efficacy as a cornerstone therapy for hormone-sensitive conditions.
View Study"Determination of Leuprolide-Fatty Acid Conjugate in Rat Plasma Using LC-MS/MS and Its Pharmacokinetics after Subcutaneous Administration in Rats"
Seong GS, Seo SW, Cho JY, 2022
Finding: Researchers developed advanced analytical methods showing that fatty acid conjugation with leuprolide significantly extends its half-life and improves pharmacokinetic properties. These modifications create longer-acting formulations, allowing patients to receive medication less frequently through depot injections.
View Study"Gonadotropin Releasing Hormone (GnRH) Analogues"
Multiple authors, 2024
Finding: GnRH agonists including leuprolide achieve profound androgen and estrogen suppression without causing clinically significant liver damage, making them safe for long-term androgen deprivation therapy in advanced prostate cancer and benign hormone-responsive conditions.
View StudyFrequently Asked Questions